This study is evaluating a new treatment for children with a rare kidney disease resulting from scar tissue in the kidney’s filtering system (the glomerulus). This part of the kidneys helps get rid of harmful waste materials in blood. If this filtering system doesn’t work properly, it may lead to kidney disease or even failure. The therapy we’re testing, the Liposorber LA-15 System, is a blood processing device that removes certain lipoproteins (known as “bad” cholesterol) from the patient’s blood. The device was first used in the U.S. to treat people whose very high cholesterol put them at significant risk for heart disease. We expect it will likely benefit children with this kidney filtering defect.
Kaneka Pharma America, LLC
Pediatric Nephrologist
Pediatric NephrologyPediatric Hypertension ClinicKidney Stone Clinic